|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-11-03 | Covance : Dow, S&P 500 close slightly lower; semis boost Nasdaq | RE |
| 14-11-03 | Covance : LabCorp to pay $6.1 billion for drug trial company Covance | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 2023-03-05 | |
Hong Gang Bi
PRN | Corporate Officer/Principal | 67 | 2011-05-30 |
Stephen Street
PRN | Corporate Officer/Principal | 65 | 2012-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Glenn Eisenberg
BRD | Director/Board Member | 64 | 2015-02-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.49% | -2.42% | +0.46% | +17.32% | 49.81B | |
| -1.11% | -2.84% | +420.04% | +505.15% | 44.06B | |
| -0.21% | +0.37% | +36.88% | +17.32% | 42.99B | |
| -1.95% | -3.33% | +8.29% | +73.25% | 40.88B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.11B | |
| -1.11% | -4.20% | +25.49% | +119.78% | 16.58B | |
| +6.10% | +4.40% | - | - | 17.27B | |
| -0.14% | -2.19% | +11.51% | +27.93% | 14.63B | |
| -1.12% | -3.46% | +76.50% | +39.37% | 13.76B | |
| Average | -0.10% | -1.37% | +74.69% | +105.87% | 30.34B | |
| Weighted average by Cap. | -0.45% | -1.50% | +88.75% | +122.53% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
